(Q37030775)

17 August 2017

1 reference

title

Clinical pharmacokinetics and pharmacodynamics of insulin glulisine (English)

1 reference

17 August 2017

1 reference

1 reference

1 reference

Reinhard H A Becker

1

1 reference

17 August 2017

Annke D Frick

series ordinal

2

1 reference

17 August 2017

language of work or name

1 reference

1 January 2008

1 reference

Clinical Pharmacokinetics

17 August 2017

1 reference

17 August 2017

47

1 reference

17 August 2017

1

1 reference

17 August 2017

7-20

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200847010-00002

17 August 2017

0 references

cites work

Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein-ligand complex

1 reference

12 December 2020

Insulin glulisine complementing basal insulins: a review of structure and activity

1 reference

12 December 2020

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

1 reference

12 December 2020

Insulin treatment in type 1 diabetes

1 reference

12 December 2020

Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment

1 reference

12 December 2020

Action profile of the rapid acting insulin analogue: human insulin B28Asp

1 reference

12 December 2020

Injection-meal interval: recommendations of diabetologists and how patients handle it.

1 reference

12 December 2020

Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces

1 reference

12 December 2020

Early events in the fibrillation of monomeric insulin.

1 reference

12 December 2020

Dose-response relationship of insulin glulisine in subjects with type 1 diabetes

1 reference

12 December 2020

Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes

1 reference

12 December 2020

Precipitation of insulin products used for continuous subcutaneous insulin infusion

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes

1 reference

12 December 2020

Mechanisms of stabilization of the insulin hexamer through allosteric ligand interactions.

1 reference

12 December 2020

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

1 reference

12 December 2020

Measurement of insulin absorption and insulin action

1 reference

12 December 2020

Insulin glulisine: a faster onset of action compared with insulin lispro.

1 reference

12 December 2020

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

1 reference

12 December 2020

Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.

1 reference

12 December 2020

Experience with insulin analogues in children

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique

1 reference

12 December 2020

In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.

1 reference

12 December 2020

Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I.

1 reference

12 December 2020

Precipitation of insulin aspart and insulin glulisine products used for continuous subcutaneous insulin infusion.

1 reference

12 December 2020

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

1 reference

12 December 2020

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

1 reference

12 December 2020

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

12 December 2020

Absorption of injected insulin. A clinical-pharmacological study

1 reference

12 December 2020

Insulins today and beyond

1 reference

12 December 2020

Altering the association properties of insulin by amino acid replacement

1 reference

12 December 2020

Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes

1 reference

12 December 2020

Intensive treatment of type 1 diabetes

1 reference

12 December 2020

Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin

1 reference

12 December 2020

The action profile of lispro is not blunted by mixing in the syringe with NPH insulin

1 reference

12 December 2020

Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects

1 reference

12 December 2020

The renal metabolism of insulin

1 reference

12 December 2020

Insulin degradation: progress and potential

1 reference

12 December 2020

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

1 reference

12 December 2020

10.2165/00003088-200847010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference